Lv5
940 积分 2024-11-29 加入
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers
17小时前
已完结
Systemic Therapy for Salivary Gland Cancers: A Review of Targeted and Chemotherapeutic Approaches
17小时前
已完结
Head and Neck Cancer: A Review
17小时前
已完结
Precision immunotherapy for head and neck cancer: therapeutic combinations, biomarker strategies, and translational challenges
17小时前
已完结
FDA Approval Summary: Tarlatamab for the Treatment of Extensive-Stage Small Cell Lung Cancer
3天前
已完结
Bench-to-Bedside Perspectives on Ocular Toxicity of Antibody–Drug Conjugates: Toxicology, Clinical Management and Molecule Optimization
5天前
已完结
Preclinical Efficacy of TSL2109 in Prostate Cancer Treatment and Overcoming Enzalutamide Resistance
9天前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
9天前
已完结
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
12天前
已完结
ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib
12天前
已完结
皖公网安备34019202002308
